Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
This poster discusses a stepwise Quality-by-Design (QbD) approach consistent with ICH Q8 (R2) and associated regulatory guidelines to build quality into a Novel ALS drug product.